The Solomon Lab joins the multi-institutional initiative between Clemson, Delaware State, Tulane, and UD to develop CHO biomanufacturing platforms for optimized production of biologics and other drugs. The Solomon Lab brings expertise in epigenomics and genomics to improve product quality and yield. REU positions will be available in summer 2021 for undergraduates. To learn more about the initiative, please check out:https://cecas.clemson.edu/CHOg2p/g2pHome
Microbes exhibit tremendous diversity and potential for biotech but only a vanishingly small fraction of it has been explored. Check out Prof. Solomon's musings on the topic in an interview with Forbes. |
Archives
February 2021
|